Skip to main content
Erschienen in: World Journal of Surgery 8/2006

01.08.2006

Postsurgical Infections are Reduced with Specialized Nutrition Support

verfasst von: Dan L. Waitzberg, MD, Hideaki Saito, MD, Lindsay D. Plank, PhD, Glyn G. Jamieson, MD, Palepu Jagannath, MD, Tsann-Long Hwang, MD, Juan M. Mijares, MD, David Bihari, MD

Erschienen in: World Journal of Surgery | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

The objective was to examine the relationship between pre-, peri-, and postoperative specialized nutritional support with immune-modulating nutrients and postoperative morbidity in patients undergoing elective surgery.

Methods

Studies were identified by searching MEDLINE, review article bibliographies, and abstracts and proceedings of scientific meetings. All randomized clinical trials in which patients were supplemented by the IMPACT formula before and/or after elective surgery and the clinical outcomes reported were included in the meta-analysis. Seventeen studies (n = 2,305), 14 published (n = 2,102), and 3 unpublished (n = 203), fulfilled the inclusion criteria. Ten studies (n = 1,392) examined the efficacy of pre- or perioperative IMPACT supplementation in patients undergoing elective surgery, whereas 7 (n = 913) assessed postoperative efficacy. Fourteen of the studies (n = 2,083) involved gastrointestinal (GI) surgical patients. Postoperative complications, mortality, and length of stay in hospital (LOS) were major outcomes of interest.

Results

IMPACT supplementation, in general, was associated with significant (39%–61%) reductions in postoperative infectious complications and a significant decrease in LOS in hospital by an average of 2 days. The greatest improvement in postoperative outcomes was observed in patients receiving specialized nutrition support as part of their preoperative treatment. In GI surgical patients, anastomotic leaks were 46% less prevalent when IMPACT supplementation was part of the preoperative treatment.

Conclusion

This study identifies a dosage (0.5–1 l/day) and duration (supplementation for 5–7 days before surgery) of IMPACT that contributes to improved outcomes of morbidity in elective surgery patients, particularly those undergoing GI surgical procedures. The cost effectiveness of such practice is supported by recent health economic analysis. Findings suggest preoperative IMPACT use for the prophylaxis of postoperative complications in elective surgical patients.
Literatur
1.
Zurück zum Zitat Tepaske R, te Velthuis H, Oudemans-van Straaten HM, et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 2001;358:696–701PubMedCrossRef Tepaske R, te Velthuis H, Oudemans-van Straaten HM, et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 2001;358:696–701PubMedCrossRef
2.
Zurück zum Zitat Heys SD, Walker LG, Smith I, et al. Enteral nutrition supplementation with key nutrients in patients with critical illness and cancer. Ann Surg 1999;229:476–477CrossRef Heys SD, Walker LG, Smith I, et al. Enteral nutrition supplementation with key nutrients in patients with critical illness and cancer. Ann Surg 1999;229:476–477CrossRef
3.
Zurück zum Zitat Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999;27:2799–2805PubMedCrossRef Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999;27:2799–2805PubMedCrossRef
4.
Zurück zum Zitat Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001;286:944–953PubMedCrossRef Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001;286:944–953PubMedCrossRef
5.
Zurück zum Zitat Montejo JC, Zarazaga A, Lopez-Martinez J, et al. Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr 2003;22:221–233PubMedCrossRef Montejo JC, Zarazaga A, Lopez-Martinez J, et al. Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr 2003;22:221–233PubMedCrossRef
6.
Zurück zum Zitat Wyncoll D, Beale R. Immunologically enhanced enteral nutrition: current status. Curr Opin Crit Care 2001;7:128–132PubMedCrossRef Wyncoll D, Beale R. Immunologically enhanced enteral nutrition: current status. Curr Opin Crit Care 2001;7:128–132PubMedCrossRef
7.
Zurück zum Zitat Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992;112:327–338 Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992;112:327–338
8.
Zurück zum Zitat Gianotti L, Braga M, Frei A, et al. Health care resources consumed to treat postoperative infections: cost savings by perioperative immunonutrition. Shock 2000;14:325–330PubMedCrossRef Gianotti L, Braga M, Frei A, et al. Health care resources consumed to treat postoperative infections: cost savings by perioperative immunonutrition. Shock 2000;14:325–330PubMedCrossRef
9.
Zurück zum Zitat Kemen M, Senkal M, Homann HH, et al. Early postoperative enteral nutrition with arginine, omega-3 fatty acids, and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of IMPACT®. Crit Care Med 1995;23:652–659PubMedCrossRef Kemen M, Senkal M, Homann HH, et al. Early postoperative enteral nutrition with arginine, omega-3 fatty acids, and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of IMPACT®. Crit Care Med 1995;23:652–659PubMedCrossRef
10.
Zurück zum Zitat Senkal M, Kemen M, Homann HH, et al. Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 1995;161:115–122PubMed Senkal M, Kemen M, Homann HH, et al. Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 1995;161:115–122PubMed
11.
Zurück zum Zitat Braga M, Gianotti L, Gestari A, et al. Gut function, immune and inflammatory responses in patients fed perioperatively with supplemented formulas. Arch Surg 1996;131:1257–1265PubMed Braga M, Gianotti L, Gestari A, et al. Gut function, immune and inflammatory responses in patients fed perioperatively with supplemented formulas. Arch Surg 1996;131:1257–1265PubMed
12.
Zurück zum Zitat Wachtler P, Hilger RA, König W, et al. Influence of a pre-operative enteral supplement on functional activities of peripheral leukocytes from patients with major surgery. Clin Nutr 1995;14:275–282PubMedCrossRef Wachtler P, Hilger RA, König W, et al. Influence of a pre-operative enteral supplement on functional activities of peripheral leukocytes from patients with major surgery. Clin Nutr 1995;14:275–282PubMedCrossRef
13.
Zurück zum Zitat Kulkarni AD, Rudolph FB, Van Buren CT. The role of dietary sources of nucleotides in immune function: a review. J Nutr 1994;124:1442S–1446SPubMed Kulkarni AD, Rudolph FB, Van Buren CT. The role of dietary sources of nucleotides in immune function: a review. J Nutr 1994;124:1442S–1446SPubMed
14.
Zurück zum Zitat Kirk SJ, Hurson M, Regan MC, et al. Arginine stimulates wound healing and immune function in elderly human beings. Surgery 1993;114:155–160PubMed Kirk SJ, Hurson M, Regan MC, et al. Arginine stimulates wound healing and immune function in elderly human beings. Surgery 1993;114:155–160PubMed
15.
Zurück zum Zitat Sato H, Zhao ZQ, McGee DS, et al. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg 1995;110:302–314PubMedCrossRef Sato H, Zhao ZQ, McGee DS, et al. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg 1995;110:302–314PubMedCrossRef
16.
Zurück zum Zitat Jones SM, Thurman RG. L-arginine minimizes reperfusion injury in a low-flow, reflow model of liver perfusion. Hepatology 1996;24:163–168PubMed Jones SM, Thurman RG. L-arginine minimizes reperfusion injury in a low-flow, reflow model of liver perfusion. Hepatology 1996;24:163–168PubMed
17.
18.
Zurück zum Zitat O’Leary MJ, Coakley JH. Nutrition and immunonutrition. Br J Anaesth 1996;77:118–127PubMed O’Leary MJ, Coakley JH. Nutrition and immunonutrition. Br J Anaesth 1996;77:118–127PubMed
19.
Zurück zum Zitat Meydani SN, Dinarello CA. Influence of dietary fatty acids on cytokine production and its clinical implications. Nutr Clin Pract 1993;8:65–72PubMed Meydani SN, Dinarello CA. Influence of dietary fatty acids on cytokine production and its clinical implications. Nutr Clin Pract 1993;8:65–72PubMed
20.
Zurück zum Zitat Calder PC. Immunoregulatory and anti-inflammatory effects of n-3-polyunsaturated fatty acids. Braz J Med Biol Res 1998;31:467–490PubMedCrossRef Calder PC. Immunoregulatory and anti-inflammatory effects of n-3-polyunsaturated fatty acids. Braz J Med Biol Res 1998;31:467–490PubMedCrossRef
21.
Zurück zum Zitat Luiking YC, Poeze M, Dehong CH, et al. Sepsis: an arginine deficiency state? Crit Care Med 2004;32(10):2135–2145PubMedCrossRef Luiking YC, Poeze M, Dehong CH, et al. Sepsis: an arginine deficiency state? Crit Care Med 2004;32(10):2135–2145PubMedCrossRef
22.
Zurück zum Zitat Burdett S, Stewart LA, Tierny JF. Publication bias and meta-analysis. Int J Technol Assess Health Care 2003;19:129–134PubMedCrossRef Burdett S, Stewart LA, Tierny JF. Publication bias and meta-analysis. Int J Technol Assess Health Care 2003;19:129–134PubMedCrossRef
23.
Zurück zum Zitat Heyland DK, MacDonald S, Keefe L, et al. Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA 1998;280:2013–2019PubMedCrossRef Heyland DK, MacDonald S, Keefe L, et al. Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA 1998;280:2013–2019PubMedCrossRef
24.
Zurück zum Zitat Jadad A. Random controlled trials. London: BMJ, 1998 Jadad A. Random controlled trials. London: BMJ, 1998
25.
Zurück zum Zitat Rothman KJ, Boice JD. Epidemiological analysis with a programmable calculator. Washington, DC, National Institutes of Health, 1979 Rothman KJ, Boice JD. Epidemiological analysis with a programmable calculator. Washington, DC, National Institutes of Health, 1979
26.
Zurück zum Zitat Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer. J Clin Epidemiol 1991;44:127–139PubMedCrossRef Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer. J Clin Epidemiol 1991;44:127–139PubMedCrossRef
27.
Zurück zum Zitat Hedges LV. Estimation of effect size from a series of independent experiments. Psychol Bull 1982;92:490–499CrossRef Hedges LV. Estimation of effect size from a series of independent experiments. Psychol Bull 1982;92:490–499CrossRef
28.
Zurück zum Zitat Braga M, Gianotti L, Vignali A, et al. Preoperative oral arginine and –3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002;132:805–814PubMedCrossRef Braga M, Gianotti L, Vignali A, et al. Preoperative oral arginine and –3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002;132:805–814PubMedCrossRef
29.
Zurück zum Zitat Gianotti L, Braga M, Nespoli L, et al. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002;122:1783–1770CrossRef Gianotti L, Braga M, Nespoli L, et al. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002;122:1783–1770CrossRef
30.
Zurück zum Zitat Braga M, Gianotti L, Nespoli L, et al. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 2002;137:174–180PubMedCrossRef Braga M, Gianotti L, Nespoli L, et al. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 2002;137:174–180PubMedCrossRef
31.
Zurück zum Zitat Daly JM, Weintraub FN, Shou J, et al. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995;221:327–338PubMed Daly JM, Weintraub FN, Shou J, et al. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995;221:327–338PubMed
32.
Zurück zum Zitat Schilling J, Vranjes N, Fierz W, et al. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solution. Nutrition 1996;12:423–429PubMedCrossRef Schilling J, Vranjes N, Fierz W, et al. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solution. Nutrition 1996;12:423–429PubMedCrossRef
33.
Zurück zum Zitat Senkal M, Mumme A, Eickhoff U, et al. Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med 1997;25:1489–1496PubMedCrossRef Senkal M, Mumme A, Eickhoff U, et al. Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med 1997;25:1489–1496PubMedCrossRef
34.
Zurück zum Zitat Heslin MJ, Latkany L, Leung D, et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg 1997;226:567–577PubMedCrossRef Heslin MJ, Latkany L, Leung D, et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg 1997;226:567–577PubMedCrossRef
35.
Zurück zum Zitat Gianotti L, Braga M, Vignali A, et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg 1997;132:1222–1230PubMed Gianotti L, Braga M, Vignali A, et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg 1997;132:1222–1230PubMed
36.
Zurück zum Zitat Jiang ZM. The role of immune enhanced enteral nutrition on plasma amino acid, gut permeability and clinical outcome in post-surgery patients. Acta Chin Acad Med Sci 2001;23:515–518 Jiang ZM. The role of immune enhanced enteral nutrition on plasma amino acid, gut permeability and clinical outcome in post-surgery patients. Acta Chin Acad Med Sci 2001;23:515–518
37.
Zurück zum Zitat Senkal M, Zumtobel V, Bauer KH, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 1999;134:1309–1316PubMedCrossRef Senkal M, Zumtobel V, Bauer KH, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 1999;134:1309–1316PubMedCrossRef
38.
Zurück zum Zitat Snyderman CH, Kachman K, Molseed L, et al. Reduced postoperative infections with an immune-enhancing nutritional supplement. Laryngoscope 1999;109:915–921PubMedCrossRef Snyderman CH, Kachman K, Molseed L, et al. Reduced postoperative infections with an immune-enhancing nutritional supplement. Laryngoscope 1999;109:915–921PubMedCrossRef
39.
Zurück zum Zitat Braga M, Gianotti L, Radaelli G, et al. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 1999;134:428–433PubMedCrossRef Braga M, Gianotti L, Radaelli G, et al. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 1999;134:428–433PubMedCrossRef
40.
Zurück zum Zitat Braga M, Bianotti L. Preoperative immunonutrition: cost-benefit analysis. J Parenter Enteral Nutr 2005;29(1):S57–S61 Braga M, Bianotti L. Preoperative immunonutrition: cost-benefit analysis. J Parenter Enteral Nutr 2005;29(1):S57–S61
41.
Zurück zum Zitat Wheeler JM, Gilbert JM. Controlled intraoperative water testing of left-sided colorectal anastomoses: are ileostomies avoidable? Ann R Coll Surg Engl 1999;81:105–108PubMed Wheeler JM, Gilbert JM. Controlled intraoperative water testing of left-sided colorectal anastomoses: are ileostomies avoidable? Ann R Coll Surg Engl 1999;81:105–108PubMed
42.
Zurück zum Zitat Strickland A, Brogan A, Krauss J, et al. Is the use of specialized nutritional formulations a cost-effective strategy? A national database evaluation. J Parenter Enteral Nutr 2005;29(1):S81–S91CrossRef Strickland A, Brogan A, Krauss J, et al. Is the use of specialized nutritional formulations a cost-effective strategy? A national database evaluation. J Parenter Enteral Nutr 2005;29(1):S81–S91CrossRef
43.
Zurück zum Zitat Vignali A, Gianotti L, Braga M, et al. Altered microperfusion at the rectal stump is predictive for rectal anastomotic leak. Dis Colon Rectum 2000;43:76–82PubMedCrossRef Vignali A, Gianotti L, Braga M, et al. Altered microperfusion at the rectal stump is predictive for rectal anastomotic leak. Dis Colon Rectum 2000;43:76–82PubMedCrossRef
Metadaten
Titel
Postsurgical Infections are Reduced with Specialized Nutrition Support
verfasst von
Dan L. Waitzberg, MD
Hideaki Saito, MD
Lindsay D. Plank, PhD
Glyn G. Jamieson, MD
Palepu Jagannath, MD
Tsann-Long Hwang, MD
Juan M. Mijares, MD
David Bihari, MD
Publikationsdatum
01.08.2006
Erschienen in
World Journal of Surgery / Ausgabe 8/2006
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-0657-x

Weitere Artikel der Ausgabe 8/2006

World Journal of Surgery 8/2006 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.